TY - JOUR
T1 - Error-related brain activity in youth and young adults before and after treatment for generalized or social anxiety disorder
AU - Kujawa, Autumn
AU - Weinberg, Anna
AU - Bunford, Nora
AU - Fitzgerald, Kate D.
AU - Hanna, Gregory L.
AU - Monk, Christopher S.
AU - Kennedy, Amy E.
AU - Klumpp, Heide
AU - Hajcak, Greg
AU - Phan, K. Luan
N1 - Funding Information:
Funding: This work was supported by National Institute of Mental Health Grants R01-MH086517 to C.S.M. and K.L.P. and R01-MH101497 to K.L.P. A.K. was supported by National Institute of Mental Health Grant T32-MH067631 to Mark Rasenick. The funding source had no involvement in study design, data collection, or manuscript preparation.
Publisher Copyright:
© 2016 Elsevier Inc.
PY - 2016/11/3
Y1 - 2016/11/3
N2 - Increased error monitoring, as measured by the error-related negativity (ERN), has been shown to persist after treatment for obsessive-compulsive disorder in youth and adults; however, no previous studies have examined the ERN following treatment for related anxiety disorders. We used a flanker task to elicit the ERN in 28 youth and young adults (8–26 years old) with primary diagnoses of generalized anxiety disorder (GAD) or social anxiety disorder (SAD) and 35 healthy controls. Patients were assessed before and after treatment with cognitive-behavioral therapy (CBT) or selective serotonin reuptake inhibitors (SSRI), and healthy controls were assessed at a comparable interval. The ERN increased across assessments in the combined sample. Patients with SAD exhibited an enhanced ERN relative to healthy controls prior to and following treatment, even when analyses were limited to SAD patients who responded to treatment. Patients with GAD did not significantly differ from healthy controls at either assessment. Results provide preliminary evidence that enhanced error monitoring persists following treatment for SAD in youth and young adults, and support conceptualizations of increased error monitoring as a trait-like vulnerability that may contribute to risk for recurrence and impaired functioning later in life. Future work is needed to further evaluate the ERN in GAD across development, including whether an enhanced ERN develops in adulthood or is most apparent when worries focus on internal sources of threat.
AB - Increased error monitoring, as measured by the error-related negativity (ERN), has been shown to persist after treatment for obsessive-compulsive disorder in youth and adults; however, no previous studies have examined the ERN following treatment for related anxiety disorders. We used a flanker task to elicit the ERN in 28 youth and young adults (8–26 years old) with primary diagnoses of generalized anxiety disorder (GAD) or social anxiety disorder (SAD) and 35 healthy controls. Patients were assessed before and after treatment with cognitive-behavioral therapy (CBT) or selective serotonin reuptake inhibitors (SSRI), and healthy controls were assessed at a comparable interval. The ERN increased across assessments in the combined sample. Patients with SAD exhibited an enhanced ERN relative to healthy controls prior to and following treatment, even when analyses were limited to SAD patients who responded to treatment. Patients with GAD did not significantly differ from healthy controls at either assessment. Results provide preliminary evidence that enhanced error monitoring persists following treatment for SAD in youth and young adults, and support conceptualizations of increased error monitoring as a trait-like vulnerability that may contribute to risk for recurrence and impaired functioning later in life. Future work is needed to further evaluate the ERN in GAD across development, including whether an enhanced ERN develops in adulthood or is most apparent when worries focus on internal sources of threat.
UR - http://www.scopus.com/inward/record.url?scp=84982844978&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84982844978&partnerID=8YFLogxK
U2 - 10.1016/j.pnpbp.2016.07.010
DO - 10.1016/j.pnpbp.2016.07.010
M3 - Article
C2 - 27495356
AN - SCOPUS:84982844978
SN - 0278-5846
VL - 71
SP - 162
EP - 168
JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry
JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry
ER -